Target intelligence / Profile preview

Toll-like receptor and NOD-like receptor (TLR and NLR)

Target
TLR and NLR
Molecular classification
Receptor, Pattern recognition receptor (PRR), Single-pass transmembrane receptor (TLRs), Cytosolic receptor (NLRs)
01

Overview

Toll-like receptors (TLRs) and NOD-like receptors (NLRs) are two major classes of pattern recognition receptors (PRRs) that detect conserved molecules associated with pathogens (PAMPs) and endogenous danger signals (DAMPs), initiating innate immune responses. TLRs are single-pass transmembrane proteins, typically expressed on the cell surface or endosomal membranes, responsible for the recognition of a broad range of microbial molecules and activating signaling cascades leading to inflammation, cytokine production, and modulation of adaptive immunity. NLRs are cytosolic receptors that sense intracellular danger signals, including microbial components and metabolic stress, and can oligomerize to form inflammasomes which mediate maturation of inflammatory cytokines such as IL-1β and IL-18. Both receptor families are implicated in numerous diseases when dysregulated, including infections, chronic inflammatory diseases, autoimmune disorders, and cancer. The designation "Toll-like receptors and NOD-like receptors" refers to two large families of related but distinct receptors, not a single molecule or canonical target. Each family comprises multiple subtypes (e.g., TLR1–TLR10, NOD1, NOD2, NLRP3, etc.), and each should ideally be considered separately in structured target databases. Therefore, this entry is overly broad and not specific to a single molecule/receptor; use with caution for structured data purposes.

Other names
Toll receptorTLR (for Toll-like receptor)NOD proteinNLR (for NOD-like receptor)nucleotide-binding oligomerization domain receptor
02

Mechanism of action

Agonists: stimulate receptor to induce immune activation, cytokine release. Antagonists/inhibitors: block receptor activation to reduce inflammation or autoimmunity. Modulation of inflammasome formation (NLRs): block or alter IL-1β/IL-18 release.

03

Biological functions

Innate immune responseSignal transductionInflammationCytokine productionCell survivalCell proliferation
04

Disease associations

Inflammatory diseaseInfectionAutoimmune diseaseCancerAllergySepsisCardiovascular diseaseNeurodegenerative disease
05

Safety considerations

Hyperactivation leads to excessive inflammation, sepsis, tissue damageRisk of autoimmunity from inappropriate recognition of self moleculesExcessive cytokine release (cytokine storm)Immunosuppression risk if inhibited chronically
06

Interacting drugs

Synthetic TLR agonists and antagonists (e.g., imiquimod [TLR7 agonist], resiquimod)

5 more in the full profile.

07

Biomarkers

Expression levels of TLR or NLR genes or proteins in tissuesCirculating cytokine levels (e.g., IL-1β, IL-18 for NLRP3 inflammasome activation; TNFα, IFNγ for TLR signaling)Specific gene mutations (NOD2/CARD15 for Crohn’s disease, NLRP3 for hereditary periodic fever syndromes)

Beyond the preview

Go deeper on Toll-like receptor and NOD-like receptor (TLR and NLR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Toll-like receptor and NOD-like receptor (TLR and NLR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call